JLV Consult SRL
JLV Consult reported total assets of €2.53m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026).
The score of JLV Consult shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +88 % Total assets +310 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
JLV Consult's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 05 Aug 2024
- Year ended 31 Dec 2022filed on 13 Jun 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
JLV Consult's financial analysis
- Solvency13.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of JLV Consult
JLV Consult's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0712.977.813
- VAT number
- BE0712977813
- Peppol
- Registered · 0208:0712977813 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Nov 2018
- Registered office
- 6534 Thuin
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
JLV Consult (SRL) has been based in Thuin since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 66,892 € and equity of 348,282 €; its revenue is not published. Its solvency stands at 13.8%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to JLV Consult
Companies in the same business, of comparable size and area, outside its group.
- Lavista Pharma Retail sale of pharmaceutical products Courcelles · balance sheet €2.47m
- Apotheek Vandenbossche Zomergem Retail sale of pharmaceutical products Lievegem · balance sheet €1.26m
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- La Compagnie Financiere et Immobiliere du Haut Escaut Retail sale of pharmaceutical products Tournai · balance sheet €2.24m
- Pharma Bury & Co Retail sale of pharmaceutical products Anderlues · balance sheet €1.63m
- Cleerpharma Retail sale of pharmaceutical products Les Bons Villers · balance sheet €2.02m
- Idespharma Retail sale of pharmaceutical products Koksijde · balance sheet €1.34m
- Pharmacity Belgium Retail sale of pharmaceutical products Saint-Gilles · balance sheet €1.82m
Frequently asked questions about JLV Consult
What is the revenue of JLV Consult?
JLV Consult files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of JLV Consult?
In Belgium, the VAT number is the company number prefixed with BE: BE0712977813 for JLV Consult, if the company is VAT-registered. Its company number (CBE) is 0712.977.813.
Where is the registered office of JLV Consult?
According to the CBE register, the registered office of JLV Consult is in 6534 Thuin.
What is the equity of JLV Consult?
At the close of the 2025 financial year, the equity of JLV Consult amounts to 348,282 €, a solvency of 13.8% of total assets.
Who manages JLV Consult?
The register lists 1 active mandates at JLV Consult. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of JLV Consult
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →